- Home
- VREX vs NPCE Comparison
VREX vs NPCE Comparison
Compare VREX & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VREX
- NPCE
- Stock Information
- Founded
- VREX 2016
- NPCE 1997
- Country
- VREX United States
- NPCE United States
- Employees
- VREX N/A
- NPCE N/A
- Industry
- VREX Industrial Machinery/Components
- NPCE Medical Specialities
- Sector
- VREX Technology
- NPCE Health Care
- Exchange
- VREX Nasdaq
- NPCE Nasdaq
- Market Cap
- VREX 327.1M
- NPCE 358.3M
- IPO Year
- VREX N/A
- NPCE 2021
- Fundamental
- Price
- VREX $7.51
- NPCE $12.58
- Analyst Decision
- VREX Strong Buy
- NPCE Buy
- Analyst Count
- VREX 2
- NPCE 7
- Target Price
- VREX $22.50
- NPCE $15.14
- AVG Volume (30 Days)
- VREX 508.3K
- NPCE 482.1K
- Earning Date
- VREX 05-08-2025
- NPCE 05-13-2025
- Dividend Yield
- VREX N/A
- NPCE N/A
- EPS Growth
- VREX N/A
- NPCE N/A
- EPS
- VREX N/A
- NPCE N/A
- Revenue
- VREX $827,500,000.00
- NPCE $84,306,000.00
- Revenue This Year
- VREX $1.78
- NPCE $20.74
- Revenue Next Year
- VREX $4.50
- NPCE $12.47
- P/E Ratio
- VREX N/A
- NPCE N/A
- Revenue Growth
- VREX N/A
- NPCE 22.05
- 52 Week Low
- VREX $6.76
- NPCE $5.45
- 52 Week High
- VREX $16.93
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- VREX 41.63
- NPCE 43.01
- Support Level
- VREX $7.37
- NPCE $10.61
- Resistance Level
- VREX $8.25
- NPCE $13.25
- Average True Range (ATR)
- VREX 0.36
- NPCE 1.64
- MACD
- VREX 0.06
- NPCE -0.52
- Stochastic Oscillator
- VREX 26.75
- NPCE 23.49
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.